You're been inactive for a while. For security reason, we'll automatically sign you out from our website. Please Click "Login" to extend your session
Access your patient history, lab results, future appointments and more.
New to Bumrungrad? Create Account
Explore the latest news and easily book appointments with our world-class doctors.
Already have an account? Log In
Tissue Plasminogen Activator (tPA) for Stroke
Ischemic stroke happens when blood flow to the brain is blocked by a blood clot. Thrombolytic therapy (tissue plasminogen activator: tPA) is a strong clot-busting medication, given intravenously, that dissolve the blood clot and reconstitute the blood flow and oxygen to the brain. Tissue plasminogen activator (tPA) is the only medication approved by the U.S. Food and Drug Administration (FDA) for acute treatment of ischemic stroke. Tissue plasminogen activator (tPA) is most effective when given within the first 4.5 hours from the stroke onset.
Related conditions
Doctors Related
Related Centers
CALL FOR APPOINTMENT
SEND AN INQUIRY
BOOK APPOINTMENT
FAST is an easy-to-remember way to recognize the signs of stroke. Learn more in our infographic.
FASTNeuro-DiseaseStroke
According to the American Heart Association, stroke was the second leading global cause of death behind heart disease in 2013, accounting for 11.8% of total deaths worldwide.
Neuro-DiseaseStroke
Minimizing the long-term effects of stroke requires fast action, an important lesson the Thanaratsuthikul family learned during the most critical moments of their mother’s stroke.